Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect
Neurology
Prevalence
5.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect?
There are 1 clinical trial targeting Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect tracked by BioSniper.
What is the prevalence of Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect?
The estimated prevalence of Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect is approximately 5.0 per 100,000 population.
Deep-dive into Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis